Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$90.5M |
| 2 |
SW
Smurfit Westrock
SW
|
+$70M |
| 3 |
Pinduoduo
PDD
|
+$28.2M |
| 4 |
Microsoft
MSFT
|
+$24.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$118M |
| 2 |
Apple
AAPL
|
+$43.5M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$27.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.62% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.21% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Kforce
KFRC
$1.08B
| $2.22M | ﹤0.01% |
36,200
-300
| -0.8% | -$19.2K |
|
1802
Winmark
WINA
$1.26B
| $2.22M | ﹤0.01% |
5,800
-100
| -2% | -$37.2K |
|
1803
Alignment Healthcare
ALHC
$2.79B
| $2.22M | ﹤0.01% |
187,600
| – | – |
|
1804
Sphere Entertainment
SPHR
$6.33B
| $2.22M | ﹤0.01% |
50,159
| – | – |
|
|
DMC
1805
Del Monte Corp
DMC
$1.44B
| $2.22M | ﹤0.01% |
75,000
| – | – |
|
1806
Apogee Therapeutics
APGE
$10.2B
| $2.21M | ﹤0.01% |
37,700
-4,500
| -11% | -$216K |
|
1807
Vita Coco
COCO
$3.77B
| $2.21M | ﹤0.01% |
78,000
| – | – |
|
1808
Scansource
SCSC
$1.06B
| $2.2M | ﹤0.01% |
45,900
-3,700
| -7% | -$175K |
|
1809
United States Lime & Minerals
USLM
$3.37B
| $2.2M | ﹤0.01% |
22,500
| – | – |
|
1810
Indivior Pharmaceuticals
INDV
$4.51B
| $2.19M | ﹤0.01% |
222,235
-4,407
| -2% | -$51.6K |
|
1811
Encore Capital Group
ECPG
$2.15B
| $2.19M | ﹤0.01% |
46,300
| – | – |
|
1812
Appian
APPN
$2.65B
| $2.19M | ﹤0.01% |
64,100
-6,500
| -9% | -$210K |
|
1813
Monarch Casino & Resort
MCRI
$2.2B
| $2.18M | ﹤0.01% |
27,511
-300
| -1% | -$22K |
|
|
JAMF
1814
DELISTED
Jamf
JAMF
| $2.18M | ﹤0.01% |
125,500
+25,600
| +26% | +$455K |
|
1815
Interface
TILE
$2.24B
| $2.17M | ﹤0.01% |
114,500
| – | – |
|
1816
MoonLake Immunotherapeutics
MLTX
$1.4B
| $2.17M | ﹤0.01% |
43,000
+12,100
| +39% | +$567K |
|
1817
Applied Digital
APLD
$8.81B
| $2.17M | ﹤0.01% |
+262,500
| New | +$1.39M |
|
|
EVRI
1818
DELISTED
Everi Holdings
EVRI
| $2.17M | ﹤0.01% |
164,800
| – | – |
|
|
PENG
1819
Penguin Solutions Inc
PENG
$3.12B
| $2.16M | ﹤0.01% |
103,300
+1,000
| +1% | +$21.5K |
|
1820
Transcat
TRNS
$888M
| $2.16M | ﹤0.01% |
17,915
-100
| -0.6% | -$12.4K |
|
1821
National Beverage
FIZZ
$2.93B
| $2.16M | ﹤0.01% |
46,000
| – | – |
|
|
EFC
1822
Ellington Financial
EFC
$1.76B
| $2.16M | ﹤0.01% |
167,400
| – | – |
|
|
AVNS
1823
DELISTED
Avanos Medical
AVNS
| $2.15M | ﹤0.01% |
89,600
-1,300
| -1% | -$29.7K |
|
1824
PureCycle Technologies
PCT
$1.41B
| $2.15M | ﹤0.01% |
226,500
| – | – |
|
|
LBPH
1825
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.15M | ﹤0.01% |
64,500
+8,300
| +15% | +$286K |
|
Similar funds
Swiss National Bank's Q3 2024 Portfolio in Review
As of Q3 2024, Swiss National Bank held 2,510 positions worth $154B, up 5.8% from $146B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.9%. Swiss National Bank opened 52 new positions and exited 45, leaving the 2,510-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2024 buy was Nu Holdings: 6,729,657 shares worth $91.9M.
- Swiss National Bank added most to Pinduoduo in Q3 2024, an estimated $28.2M increase.
- Swiss National Bank's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $118M.
- Swiss National Bank fully exited WestRock Company in Q3 2024, selling an estimated $38.2M.
- Swiss National Bank's ten largest holdings make up 32% of its $154B portfolio in Q3 2024.
- Swiss National Bank opened 52 new positions and closed 45 in Q3 2024.
- Swiss National Bank's portfolio value rose 5.8% quarter-over-quarter to $154B.
Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.